CONNEXA Announces $5.0 Million Private Placement

Written by Customer Service on September 28, 2022. Posted in Public Companies.

BALTIMORE, Md., Sept. 28, 2022 (GLOBE NEWSWIRE) — Connexa Sports Technologies, Inc. (NASDAQ: CNXA) (“Connexa”), today announced that it has entered into a securities purchase agreement with a single institutional investor for the issuance and sale of 12,820,512 shares of its common stock (or common stock equivalents in lieu thereof), together with accompanying common stock warrants, at a combined purchase price of $0.39 per share (or common stock equivalents) and accompanying warrants in a private placement. The shares of common stock (or common stock equivalents) were sold in the offering together with 12,820,512 warrants to purchase 12,820,512 shares of common stock at an exercise price of $0.39 per share and a term of five years following the initial exercise date and 25,641,024 warrants to purchase 25,641,024 shares of common...

CVR Partners 2021 Schedule K-3 Now Available

Written by Customer Service on September 28, 2022. Posted in Public Companies.

SUGAR LAND, Texas, Sept. 28, 2022 (GLOBE NEWSWIRE) — CVR Partners, LP (NYSE: UAN) today announced that 2021 Schedule K-3s, reflecting items of international tax relevance, are now available online. Unitholders may access the information at www.taxpackagesupport.com/cvrpartners. A limited number of investors (primarily foreign unitholders, unitholders computing a foreign tax credit on their tax return and certain corporate and/or partnership unitholders) may need the detailed information disclosed on the Schedule K-3 for their specific reporting requirements. To the extent the Schedule K-3 is applicable to a unitholder’s federal income tax return filing needs, unitholders are encouraged to review the information contained on this form and refer to the appropriate federal laws or consult with their tax advisor. CVR Partners does...

Aligos Therapeutics Files Response to Janssen Biopharma Lawsuit and Lodges Counterclaims Alleging Unfair Competition and Promissory Fraud

Written by Customer Service on September 28, 2022. Posted in Public Companies.

SOUTH SAN FRANCISCO, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, has filed a response to the complaint of, and counterclaims against, Janssen Biopharma in California State Superior Court for the County of San Mateo. The response to Janssen’s complaint specifically identifies the decades old publicly available information (published patents and scientific literature), previous work experience, publications and patents by the Aligos co-founders at other oligonucleotide companies towards the first discovery of oligonucleotides (ASO and siRNA) targeting hepatitis B virus (HBV), as well as the licenses Aligos obtained from universities and biotechnology...

Lincoln Electric Schedules Webcast for Third Quarter 2022 Results

Written by Customer Service on September 28, 2022. Posted in Public Companies.

CLEVELAND, Sept. 28, 2022 (GLOBE NEWSWIRE) — Lincoln Electric Holdings, Inc., (the “Company”) (Nasdaq: LECO) announced today that it will release its third quarter 2022 results on Thursday, October 27, 2022 prior to market open. An investor conference call and webcast will take place at 10:00 a.m. (ET) later that day. Those interested in participating via webcast in listen-only mode may access the event here or on the Company’s Investor Relations home page at https://ir.lincolnelectric.com. For participants who would like to participate via telephone, please register here to receive the dial-in number along with a unique PIN number that is required to access the call. A replay of the earnings call will be available via webcast on the Company’s website. About Lincoln Electric Lincoln Electric is the world leader in the...

Devon Energy Completes Acquisition of Eagle Ford Bolt-On

Written by Customer Service on September 28, 2022. Posted in Mergers And Acquisitions.

OKLAHOMA CITY, Sept. 28, 2022 (GLOBE NEWSWIRE) — Devon Energy Corp. (NYSE: DVN) today announced that it has completed its previously announced acquisition of Validus Energy, an Eagle Ford operator, for a total cash consideration of $1.8 billion, less purchase price adjustments. This acquisition secures a premier acreage position of 42,000 net acres (90% working interest) adjacent to Devon’s existing leasehold in the basin. Current production from the acquired assets is approximately 35,000 Boe per day and is expected to increase to an average of 40,000 Boe per day over the next year. The transaction also adds 350 repeatable drilling locations in the core of the Karnes Trough oil window along with 150 high-quality refrac candidates. This highly economic inventory positions the company’s Eagle Ford assets to sustain its high-margin...

Concentrix Reports Third Quarter 2022 Results

Written by Customer Service on September 28, 2022. Posted in Earnings Releases And Operating Results.

Raises Quarterly Dividend 10 Percent NEWARK, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) — Concentrix Corporation (NASDAQ: CNXC), a leading global provider of customer experience (CX) solutions and technology, today announced financial results for the fiscal third quarter ended August 31, 2022. The Company also announced that the Board of Directors has declared a 10 percent increase in its regular quarterly dividend to $0.275 per share. Three Months Ended August 31, 2022 August 31, 2021 Change Revenue($M) $ 1,579.6 $ 1,397.3 13.1% Operating income($M) $ 157.5 $ 151.4 4.0% Non-GAAP operating income($M)(1) $ 221.5 $ 181.6 22.0% Operating margin 10.0 % 10.8 % -80 bps Non-GAAP operating margin(1) 14.0 % 13.0 % 100 bps Net income($M) $ 106.7 $ 109.8 (2.8)% Non-GAAP...

Idera Pharmaceuticals Acquires Aceragen

Written by Customer Service on September 28, 2022. Posted in Mergers And Acquisitions.

Acquisition includes late-stage rare disease portfolio with anticipated 2023 clinical milestones and first potential product approval as early as late 2024 Conference call and webcast today at 5:00 p.m. ET EXTON, Pa. and DURHAM, N.C., Sept. 28, 2022 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,” “us,” or “our”) (Nasdaq: IDRA) today announced it has completed the acquisition of Aceragen, Inc. (“Aceragen”), a privately-held biotechnology company addressing rare, orphan pulmonary and rheumatic diseases for which there are limited or no available treatments. The combined cash of the two companies is expected to provide runway into Q3 2023, funding the advancement of Aceragen’s pipeline, including ACG-701 and ACG-801, through important 2023 clinical milestones. The Company estimates annual peak sales potential...

Isoray Announces Transformational Merger and Fourth Quarter and Full-Year Fiscal Year End 2022 Financial Results

Written by Customer Service on September 28, 2022. Posted in Earnings Releases And Operating Results.

RICHLAND, Wash., Sept. 28, 2022 (GLOBE NEWSWIRE) — Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, today announced that it has entered into a definitive agreement to acquire Viewpoint Molecular Targeting, Inc. (Viewpoint) a precision oncology company developing alpha-particle therapies and complementary diagnostic imaging agents. Under the terms of the agreement, a newly formed wholly owned subsidiary of Isoray will merge with and into Viewpoint, with Viewpoint becoming a wholly owned subsidiary of Isoray. At the effective time of the merger, each issued and outstanding share of common stock of Viewpoint will be converted into the right to receive 3.3212 shares of Isoray common stock. Other than cash paid in lieu of fractional shares, there will be no cash consideration paid...

Cumulus Media Welcomes Afford Anything Podcast to the Cumulus Podcast Network

Written by Customer Service on September 28, 2022. Posted in Public Companies.

Investor and Award-Winning Journalist Paula Pant Hosts NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) — Cumulus Media (NASDAQ: CMLS) today announced the podcast Afford Anything has joined the Cumulus Podcast Network. Creator and host Paula Pant helps listeners make smarter decisions about money, time, and life to align daily behaviors and habits with lifestyle goals. In the podcast, Pant also talks with guests about investing, travel, lifestyle design, financial independence, real estate, entrepreneurship, productivity, personal development, and the philosophy of money. A new episode of Afford Anything drops each Wednesday with a bonus episode the first Friday of each month. The podcast is available on Apple Podcasts, Spotify, Stitcher, TuneIn, Pocket Casts, and Google Podcasts, among other platforms. The Cumulus Podcast Network will...

Rivalry Announces New Date for Virtual Investor Day: Event to be Held on October 12, 2022

Written by Customer Service on September 28, 2022. Posted in Public Companies.

TORONTO, Sept. 28, 2022 (GLOBE NEWSWIRE) — Rivalry Corp. (the “Company” or “Rivalry”) (TSXV: RVLY) (OTCQX: RVLCF) (FSE: 9VK), an internationally regulated sports betting and media company, today announced updated timing for its Virtual Investor Day. The event will now be held on Wednesday, October 12, 2022, beginning at 10:00 am EDT. To attend the event, please register here: Rivalry Investor Day – webinar.net Rivalry’s inaugural Investor Day will include presentations and commentary from a cross-section of the leadership team. The sessions will provide insights into Rivalry’s growth over the past year, the key elements of its strategy, and the initiatives expected to drive growth into 2023 and beyond. The Investor Day event is expected to last approximately 1.5 hours. Participants may register in advance to view the listen-only...

Day: September 28, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice